First-line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age-matched general population: A pooled post hoc analysis / Ghia, P., Owen, C., Allan, J.N., Barrientos, J.C., Barr, P.M., Shi, C., Szoke, A., Abbazio, C., Krigsfeld, G.S., Burger, J.A.. - In: HEMASPHERE. - ISSN 2572-9241. - 8:5(2024). [10.1002/hem3.74]
First-line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age-matched general population: A pooled post hoc analysis
Ghia, Paolo
Primo
;
2024-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
HemaSphere - 2024 - Ghia - First‐line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with.pdf
accesso aperto
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Creative commons
Dimensione
855.14 kB
Formato
Adobe PDF
|
855.14 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
